Navigation Links
Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
Date:7/7/2008

e available approximately one hour after completion of the call. To access the telephone replay, dial 888-286-8010 (domestic) or 617-801-6888 (international), passcode 84526379. The webcast and telephone replay will be available through July 21, 2008.

About Anadys

Anadys Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company dedicated to improving patient care by developing novel medicines in the areas of hepatitis C and oncology. For the treatment of chronic hepatitis C, the Company is developing ANA598, a non-nucleoside polymerase inhibitor, and ANA773, an oral TLR7 agonist prodrug. The Company is also developing ANA773 for the treatment of cancer.

Safe Harbor Statement

Statements in this press release that are not strictly historical in nature constitute "forward-looking statements". Such statements include, but are not limited to, references to (i) the expected timing and planned development activities for ANA773, including the timing for commencing dosing in the planned ANA773 HCV clinical trial; (ii) the belief that ANA773 has the potential to demonstrate benefit in patients infected with HCV; (iii) the belief that the TLR7 mechanism will potentially be complementary to ANA598; (iv) expectations regarding Anadys' cash utilization for 2008; (v) the planned study design of the two-part protocol of the ANA773 clinical trial in HCV; (vi) Anadys' expectation to begin dosing HCV-infected patients with ANA773 prior to the completion of the healthy volunteer portion of the study at a dose that will have demonstrated a desired magnitude of immune stimulation in the healthy subjects; and (vii) the belief that ANA773 can elicit immune stimulation of a magnitude sufficient to confer therapeutic potential without adverse safety issues. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause Anadys' actual results to be materially different from historical results or from any
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
2. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
3. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
4. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
5. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
6. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
7. Isis Pharmaceuticals Conference Call Notice
8. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
9. XTL Biopharmaceuticals Announces Completion of Patient Randomization Into the Bicifadine Phase 2b Clinical Trial for the Treatment of Diabetic Neuropathic Pain
10. MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting
11. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... , March 2, 2015 ... the population with nearly 38,000 of those ... Staphylococcus Aureus), a highly contagious disease, infects ... deaths.  Each of these and more, not ... through casual contact with other infectious individuals, ...
(Date:3/2/2015)... -- Leading patient advocacy organization Fight Colorectal Cancer and ... One Million Strong campaign to spotlight colorectal ... funds for colorectal cancer education, research and prevention while ... living in the United States ... every day. Showing Strength for Colorectal Cancer ...
(Date:3/2/2015)... , Mar. 02, 2015 Research and Markets ... addition of the "Lopinavir - Comprehensive patent ... Imagine having your own team of ... button. Used by the world,s leading ... years, these searches are the benchmark in comprehensive, ...
Breaking Medicine Technology:Cleanint Rolls Out Cleanstethoscope and Cleanhands to Largest Medical Transportation Company in the Nation 2Cleanint Rolls Out Cleanstethoscope and Cleanhands to Largest Medical Transportation Company in the Nation 3Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 2Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 3Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 4Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 5Global Comprehensive Lopinavir Patent Search Online Portal 2015 2
... Sept. 17 Pharmasset, Inc.,(Nasdaq: VRUS ) management ... held from September 22-25, 2008 at the Grand Hyatt ... Officer,will provide an overview of the company on Wednesday, ... To access a live webcast of Mr. Price,s ...
... CT Colonography Trial Raise Questions for,Patients, OAK ... CT Colonography Trial, published in the September 18 ... improvements in the technology,s,ability to diagnose intermediate- to ... testing is not as effective in diagnosing small ...
Cached Medicine Technology:Pharmasset to Present at the UBS Global Life Sciences Conference on Wednesday, September 24th 2ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options 2ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options 3ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options 4ASGE Encourages Patients to Speak to Their Doctor About Colorectal Cancer Screening Options 5
(Date:3/2/2015)... March 02, 2015 Éminence Organic Skin ... care, is excited to announce the launch of the ... an effective, time-saving solution for those with combination skin. ... in 1 divided jar to separate the products, consists ... Treatment. The Balancing Moisturizer Duo, also in a divided ...
(Date:3/1/2015)... 02, 2015 To help ... manage their practices compliantly and profitably, MDreferralPRO ... solution. The interoperability between a strategic ... medical practice management system is necessary for ... sustainability. A referral management and development solution ...
(Date:3/1/2015)... 01, 2015 Women’s Excellence is pleased ... terms on their website. There are over 75 terms ... time. , “This gives our patients a better understanding ... terminology that they may not understand. With this resource, our ... mobile optimized) and find terms and phrases that they may not ...
(Date:3/1/2015)... (PRWEB) March 01, 2015 Adults who ... insurance rates for term or universal policies can now ... of the best life insurance companies for single adults ... system at http://quotespros.com/life-insurance.html . , The rate plans ... portal are tied to a number of life protection ...
(Date:3/1/2015)... (PRWEB) March 01, 2015 Ticket Down is ... in Chicago at Soldier Field. Deadheads have been ... in January. , Grateful Dead was formed 50 years ago ... were together as one until the untimely death of Jerry ... combining different genres including blues, reggae, rock, bluegrass, folk, space ...
Breaking Medicine News(10 mins):Health News:Éminence Organic Skin Care Launches Innovative Collection for Combination Skin 2Health News:Éminence Organic Skin Care Launches Innovative Collection for Combination Skin 3Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 2Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 3Health News:Power Up Physician and Patient Referral Management While Qualifying for ARRA Incentives 4Health News:Best Life Insurance Companies for Single Adults Now Searchable at Insurance Website 2Health News:Grateful Dead Tickets at Soldier Field in Chicago: Ticket Down Slashes Grateful Dead Ticket Prices in Chicago at Soldier Field for 4th of July Weekend Celebration 2
... Jan. 27 The Michael J. Fox Foundation ... for seven Parkinson,s drug development projects. The funding ... track of the Foundation,s industry-focused Therapeutics Development ... Therapeutics Development Initiative , the Foundation aims to ...
... dropped regulations overseeing the performance of two common heart ... researchers at Baylor College of Medicine (BCM), Rice University ... online in the journal Health Services Research . ... or CON, require hospitals to obtain approval from a ...
... bone density but short-term use safe, researchers say , , ... heart failure drugs called loop diuretics does not appear to ... study finds, but their effect over the long term is ... as Lasix, Bumex and Demadex, which are commonly prescribed to ...
... Is beauty really in the eye of the,beholder? Does ... Are,males truly the more promiscuous sex? These and other fascinating ... OF SEX,APPEAL, premiering Sunday, February 8 at 9 PM ET ... SCIENCE OF SEX APPEAL delves into our ...
... and even government officials are using the internet ... a report to be published in the ... Lorence of Penn State Center for Technology Assessment, ... growth of the internet as an information source ...
... Honored at Adrian Awards Gala Jan. 26, 2009 in New York ... ... 2009 -- EliteMeetings.com received a Bronze Adrian Award for ... Association International (HSMAI) 52nd annual Adrian Awards Competition. The Adrian Awards ...
Cached Medicine News:Health News:Michael J. Fox Foundation Awards $2.5 Million for Parkinson's Drug Development Projects Led By Academic Investigators 2Health News:Easing regulations does not mean lower quality of cardiac care 2Health News:Some Heart Failure Meds May Raise Fracture Risk in Women 2Health News:Some Heart Failure Meds May Raise Fracture Risk in Women 3Health News:This February Discovery en Espanol Delves Into The Subconscious World of Attraction in 'Science of Sex Appeal' 2Health News:This February Discovery en Espanol Delves Into The Subconscious World of Attraction in 'Science of Sex Appeal' 3Health News:Pharmaceutical disobedience 2Health News:Elitemeetings.com Wins Bronze in HSMAI'S Annual Adrian Awards Competition 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: